摘要
目的检测慢性阻塞性肺疾病(COPD)患者外周血单个核细胞(PBMCs)中微小RNA-31(miR-31)表达量并探讨其临床意义。方法采用实时荧光定量聚合酶链反应(qPCR)的方法检测38例COPD患者(COPD组)、15例急性支气管炎(AB)患者(AB组)和40例体检健康者(对照组)PBMCs中miR-31的表达,并对15例治疗后患者进行跟踪检测。酶联免疫吸附测定法(ELISA)检测COPD患者血浆中白细胞介素4(IL-4)和γ-干扰素(IFN-γ)水平。结果 COPD患者PBMC中miR-31的表达明显高于对照组和AB组,AB组PBMC中miR-31的表达明显高于对照组;COPD患者治疗后好转后miR-31的表达明显下降;COPD患者临床症状严重者其PBMC中miR-31的表达更高,COPD患者PBMC中miR-31的表达与血浆CRP水平呈负相关(r=-0.663 8,P<0.05),COPD患者PBMC中miR-31的表达与血浆中IL-4水平呈负相关(r=-0.476 4,P<0.05)。结论 COPD患者PBMC中miR-31的表达参与COPD的发生与发展,其可能在Th2类细胞中起重要作用。
Objective To investigate the expression of miR-31 in peripheral blood mononuclear cells(PBMCs)of patients with chronic obstructive pulmonary disease(COPD)and explore its clinical significance.Methods The expression of miR-31 in PBMCs from 38 patients with COPD(COPD group),15 patients with acute bronchitis(AB group),40 Healthy persons(control group)and 15 patients treated after tracking were measured by qPCR.The plasma level of IL-4 and IFN-γin patients with COPD were measured by enzyme linked immunosorbent assay.Results The expression of miR-31 in PBMC of patients with COPD was higher than AB group and control group,the expression of miR-31 in PBMC of patients with AB group were higher than control group,and it was decreased after treatment in patients with COPD;The expression of miR-31 in serious patients with COPD was higher than the other patients,the expression of miR-31 in patients with COPD was negative correlated with CRP level(r=-0.663 8,P<0.05).The expression of miR-31 in patients with COPD was negative correlated with the level of IL-4 in plasma(r=-0.476 4,P<0.05).Conclusion The expression of miR-31 in patients with COPD is significantly increased,which is related with the occurrence and development of COPD,and it is probably to impact the function of Th2 type cells.
引文
[1]BARNES P J,STOCKLEY R A.Copd:Current therapeutic interventions and future approaches[J].Europ Respir J,2005,25(6):1084-1106.
[2]SOLER J J,MARTINEZ M A,ROMAN P,et al.Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease[J].Thorax,2005,60(11):925-931.
[3]SOLER N,EWIG S,TORRES A,et al.Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease[J].Europ Respir J,1999,14(5):1015-1022.
[4]YANG S,XIE N,CUI H,et al.miR-31is a negative regulator of fibrogenesis and pulmonary fibrosis[J].Faseb J,2012,26(9):3790-3799.
[5]MOFFETT H F,CARTWRIGHT N R,KIM H J,et al.The microRNA miR-31inhibits CD8+T cell function in chronic viral infection[J].Nat Immunol,2017,18(7):791-799.
[6]MACNEE W.Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease[J].Proc Amer Thorac Soc,2005,2(1):50-60.
[7]KANG M J,LEE C G,LEE J Y,et al.Cigarette smoke selectively enhances viral PAMP-and virus-induced pulmonary innate immune and remodeling responses in mice[J].J Clin Invest,2008,118(8):2771-2784.
[8]MILARA J,JUAN G,PEIRO T,et al.Neutrophil activation in severe,early-onset COPD patients versus healthy non-smoker subjects in vitro:Effects of antioxidant therapy[J].Respiration,2012,83(2):147-158.
[9]FORSSLUND H,YANG M,MIKKO M,et al.Gender differences in the T-cell profiles of the airways in copd patients associated with clinical phenotypes[J].InterJChro Dis,2017,12(12):35-48.
[10]DEMEO D L,CAREY V J,CHAPMAN H A,et al.Familial aggregation of FEF(25-75)and FEF(25-75)/FVCin families with severe,early onset COPD[J].Thorax,2004,59(5):396-400.
[11]WANG M,HUANG Y,LIANG Z,et al.Plasma miRNAs might be promising biomarkers of chronic obstructive pulmonary disease[J].Clin Respir J,2016,10(1):104-111.
[12]LACEDONIA D,PALLADINO G P,FOSCHINO-BAR-BARO M P,et al.Expression profiling of miRNA-145and miRNA-338in serum and sputum of patients with copd,asthma,and asthma-copd overlap syndrome phenotype[J].Inter J Chro Dis,2017,12(7):1811-1817.
[13]MA Y,CHEN Y,LIN J,et al.Circulating miR-31as an effective biomarker for detection and prognosis of human cancer:A meta-analysis[J].Oncotarget,2017,8(17):28660-28671.
[14]YU M,LIANG H,FU Z,et al.BAP1suppresses lung cancer progression and is inhibited by mir-31[J].Oncotarget,2016,7(12):13742-13753.
[15]OKUDELA K,TATEISHI Y,UMEDA S,et al.Allelic imbalance in the miR-31host gene locus in lung cancer-its potential role in carcinogenesis[J].PLoS One,2014,9(6):e100581.
[16]VALASTYAN S,REINHARDT F,BENAICH N,et al.A pleiotropically acting microRNA,miR-31,inhibits breast cancer metastasis[J].Cell,2009,137(6):1032-1046.
[17]LV C,LI F,LI X,et al.miR-31promotes mammary stem cell expansion and breast tumorigenesis by suppressing wnt signaling antagonists[J].Nature Com,2017,8(1):1036.
[18]MALARDO T,GARDINASSI L G,MO-REIRA B P,et al.MicroRNA expression signatures in lungs of mice infected with mycobacterium tuberculosis[J].Tuberculosis,2016,101(12):151-159.
[19]ZHOU M,YU G,YANG X,et al.Circulating microRNAs as biomarkers for the early diagnosis of childhood tuberculosis infection[J].Mole Med Rep,2016,13(6):4620-4626.
[20]BHELA S,ROUSE B T.miR-31:A key player in CD8T-cell exhaustion[J].Cell Mole Immunol,2017,14(12):954-956.
[21]BORSKA L,ANDRYS C,CHMELAROVA M,et al.Roles of miR-31and endothelin-1in psoriasis vulgaris:Pathophysiological functions and potential biomarkers[J].Physiol Res,2017,66(6):987-992.
[22]范薇,唐元家,曲波,等.系统性红斑狼疮患者外周血细胞miR-31的表达[J].上海交通大学学报(医学版),2011,31(1):39-42.
[23]赵静,陈光辉,刘德军,等.原发性肺癌患者外周血中microRNA-31的表达及意义[J].郑州大学学报(医学版),2014,49(5):684-686.
[24]VAN DER HEIDE V,MOHNLE P,RINK J,et al.Down-regulation of microRNA-31in CD4+T cells contributes to immunosuppression in human sepsis by promoting TH2skewing[J].Anesthesiol,2016,124(4):908-922.
[25]LUAN L,SHI J,YU Z,et al.The major miR-31target genes STK40and LATS2and their implications in the regulation of keratinocyte growth and hair differentiation[J].Exper Dermatol,2017,26(6):497-504.
[26]WU D,WANG B,SHANG J,et al.miR-31reduces cell growth of papillary thyroid carcinoma by RNA-binding protein HUR[J].Clin Labor,2015,61(11):1625-1634.